Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.
- DOI
- 10.3389/fphar.2024.1383831
- Published
- 2024
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2024.1383831,
title = {Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.},
author = {Lu CL and Yang LQ and Jin XY and Friedemann T and Li YF and Liu XH and Chen XY and Zou XY and Zhang BR and Wang FX and Lin YL and Tang YM and Cao ML and Jiang YL and Gao YF and Liu K and Tao ZG and Robinson N and Schröder S and Liu JP and Lu HZ},
year = {2024},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2024.1383831},
url = {https://doi.org/10.3389/fphar.2024.1383831}
}RIS
TY - JOUR TI - Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial. AU - Lu CL AU - Yang LQ AU - Jin XY AU - Friedemann T AU - Li YF AU - Liu XH AU - Chen XY AU - Zou XY AU - Zhang BR AU - Wang FX AU - Lin YL AU - Tang YM AU - Cao ML AU - Jiang YL AU - Gao YF AU - Liu K AU - Tao ZG AU - Robinson N AU - Schröder S AU - Liu JP AU - Lu HZ PY - 2024 JO - Frontiers in pharmacology DO - 10.3389/fphar.2024.1383831 UR - https://doi.org/10.3389/fphar.2024.1383831 ER -
APA
CL, L., LQ, Y., XY, J., T, F., YF, L., XH, L., XY, C., XY, Z., BR, Z., FX, W., YL, L., YM, T., ML, C., YL, J., YF, G., K, L., ZG, T., N, R., S, S., JP, L., & HZ, L. (2024). Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2024.1383831
Source records
- pubmed · retrieved 2026-09-26T09:37:47.511Z